• DRAMP ID

    • DRAMP21386
    • Peptide Name

    • SP13 (De Novo Synthesis)
    • Source

    • synthetic construct
    • Family

    • Not found
    • Gene

    • Not found
    • Sequence

    • HFKIRKRFVKKLV
    • Sequence Length

    • 13
    • UniProt Entry

    • No entry found
    • Protein Existence

    • Synthetic form
    • Biological Activity

    • Antimicrobial, Antibacterial, Anti-Gram-
    • Target Organism

      • [Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL)
    • Hemolytic Activity

      • [Ref.31163671] 10% hemolysis at >100 μg/mL against human blood cells.
    • Cytotoxicity

      • [Ref.31163671] The cell viability of Hepa 1-6 induced by SP13 is 104.1%, 106.8%, 111.5%, 101.4%, 107.4%, 118.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.
    • Binding Target

    • Not found
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Amidation
    • Nonterminal Modifications and Unusual Amino Acids

    • None
    • Stereochemistry

    • L
    • Structure

    • α-helix mainly
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP21386 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP21386.
    • Formula

    • C82H139N25O14
    • Absent Amino Acids

    • ACDEGMNPQSTWY
    • Common Amino Acids

    • K
    • Mass

    • 1699.16
    • PI

    • 12.03
    • Basic Residues

    • 7
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 6
    • Net Charge

    • +7
    • Boman Index

    • -3282
    • Hydrophobicity

    • -0.423
    • Aliphatic Index

    • 104.62
    • Half Life

      • Mammalian:3.5 hour
      • Yeast:10 min
      • E.coli:>10 hour
    • Extinction Coefficient Cystines

    • 0
    • Absorbance 280nm

    • 0
    • Polar Residues

    • 0

DRAMP21386

    • Function

    • Antibacterial activity against Gram-negative bacteria.
  • ·Literature 1
    • Title

    • De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.
    • Reference

    • Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.
    • Author

    • Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava